BANL vs GEOS

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score, limiting bankruptcy risk assessment. Profitability metrics are deeply negative, with ROE at -14.24% and operating margin at -0.27%, while revenue has declined 4.4% year-over-year. Valuation ratios like Price/Sales of 0.02 and Price/Book of 0.42 suggest apparent cheapness, but these are offset by deteriorating fundamentals, lack of analyst coverage, and a technical trend scoring 0/100. The stock has lost over 90% of its value in the past five years, reflecting persistent operational and market challenges.

GEOS exhibits severe financial distress characterized by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. The company is suffering from a massive revenue contraction (-31.3% YoY) and consistent earnings misses, with an average surprise of -75.02% over the last four quarters. While the balance sheet remains clean with very low debt (Debt/Equity 0.01), the operational collapse is evident in the crashing stock price, which has fallen over 62% in the last six months. The combination of negative margins and plummeting growth makes the current valuation unsustainable despite trading near book value.